Cargando…
Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy
BACKGROUND: Palonosetron is a recently introduced 5-hydroxytryptamine-3 (5-HT(3)) receptor antagonist useful for postoperative nausea and vomiting prophylaxis. However, 5-HT(3) receptor antagonists increase the corrected QT (QTc) interval in patients who undergo general anesthesia. This retrospectiv...
Autores principales: | Min, Jeong Jin, Yoo, Yongjae, Kim, Tae Kyong, Lee, Jung-Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Anesthesiologists
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866334/ https://www.ncbi.nlm.nih.gov/pubmed/24363841 http://dx.doi.org/10.4097/kjae.2013.65.5.397 |
Ejemplares similares
-
The intravenously administered palonosetron does not affect the spinal anesthesia
por: Kim, Myoung-Hun, et al.
Publicado: (2013) -
Palonosetron-Induced Anaphylaxis During General Anesthesia: A Case Report
por: Park, Hyungjun, et al.
Publicado: (2017) -
Seizure developed after palonosetron intravenous injection during recovery from general anesthesia -A case report-
por: Park, Pyung-Gul, et al.
Publicado: (2012) -
Impact of Palonosetron on Cough Suppression in Females Undergoing Sevoflurane-Remifentanil Anesthesia for Laparoscopic Cholecystectomy: A Randomized Trial
por: Gil, Ho-Young, et al.
Publicado: (2021) -
Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
por: Kimura, Seishi, et al.
Publicado: (2017)